Doctor accused of leak to drug maker
New York Times, January 31, 2008
The prominent diabetes expert Dr. Steven M. Haffner of the University of Texas Health Science Center in San Antonio leaked an unpublished and confidential medical journal article to GlaxoSmithKline last year, tipping the company to the imminent publication of safety questions involving the company's diabetes drug Avandia. Haffner faxed the article to the drug maker after agreeing to read it as part of the peer-review process for The New England Journal of Medicine, according to a statement by Senator Charles E. Grassley, Republican of Iowa. Besides violating The New England Journal's rules, disclosing a pending article would also be considered a breach of professional ethics.
- NFP Hospitals' Revenue Growth at 'All-Time Low'
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Transforming Cancer Care
- Acute Kidney Injury Gets New Focus
- Interventional Radiology No Longer a Sub-Specialty
- Sharp HealthCare Leaves Pioneer ACO Program
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- mHealth Tackles Readmissions
- Report: Enrollees still face account problems on Healthcare.gov
- Proton Beam Therapy Poised for Growth in US